NSECertificate under SEBI (Depositories and Participants) Regulations, 201810 Jul 2026 · 10 Jul 2026, 04:41 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Marksans Pharma Limited · MARKSANS

✦ AI SummaryRegulatory

Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026

Attachments (1)

📄

MARKSANS_10072026164030_SEintimation.pdf

pdf

Download →
View document text
Date: July 10, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department PhirozeJeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, Kindly find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company. You are requested to note the above in your records. Thanking You. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Encl: As Above Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com Ref No. BSS/74(5) Date: 09/07/2026 MARKSANS PHARMA LTD FV 1 11TH FLOOR, GRANDEUR VEERA DESAI, EXTENSION ROAD OSHIWARA, ANDHERI WEST MUMBAI 400053 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2026. Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019 In reference to above - captioned Regulation, we hereby confirm that no dematerlisation request for equity shares of your company were received during the period from 01.04.2026 to 30.06.2026. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For BIGSHARE SERVICES PVT LTD. Sandeep More Authorised Signatory. CIN – U99999MH1994PTC076534 Regd. Office: Office No. S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (EAST), Mumbai – 400 093. Email: info@bigshareonline.com | Tel. No. +91-22-62638200| website: www.bigshareonline.com